Concepedia

Uriel M. Malyankar

UM

Statistics

Publications

9

Citations

1.2K

H-Index

9

Active since

1991

Affiliations

MannKind Corporation (United States)(Current)

University of Washington

Uriel M. Malyankar is an author at MannKind Corporation (United States) specializing in life sciences, molecular biology, and cell signaling.

Publications per year

1991–2012

9

Publications

9

Blockade of XBP1 splicing by inhibition of IRE1α is a promising therapeutic option in multiple myeloma

Naoya Mimura, Mariateresa Fulciniti, Güllü Görgün et al. · Blood · 2012 · 435 citations · Full text

Life Sciences, Molecular Biology, Molecular Medicine +9

Osteoprotegerin Is an αvβ3-induced, NF-κB-dependent Survival Factor for Endothelial Cells

Uriel M. Malyankar, Marta Scatena, Katherine L. Suchland et al. · Journal of Biological Chemistry · 2000 · 348 citations · Full text

Life Sciences, Cell Biology, Apoptosis +16

Potent and Selective Inhibitors of the Inositol-requiring Enzyme 1 Endoribonuclease

Kori Volkmann, Julie L. Lucas, D Vuga et al. · Journal of Biological Chemistry · 2011 · 211 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +13

Osteopontin regulation in cultured rat renal epithelial cells

Uriel M. Malyankar, Manuela Almeida, Richard J. Johnson et al. · Kidney International · 1997 · 63 citations · Full text

Medicine, Nephrology, Cell Signaling +4

Lymph Node–Targeted Immunotherapy Mediates Potent Immunity Resulting in Regression of Isolated or Metastatic Human Papillomavirus–Transformed Tumors

Brenna L. Meisenburg, Victor Tam, Robb R. Pagarigan et al. · Clinical Cancer Research · 2009 · 38 citations · Full text

Life Sciences, Immunology, Oncology +17

1–5 of 9